Cargando…

Microporous/Macroporous Polycaprolactone Scaffolds for Dental Applications

This study leverages the advantages of two fabrication techniques, namely, melt-extrusion-based 3D printing and porogen leaching, to develop multiphasic scaffolds with controllable properties essential for scaffold-guided dental tissue regeneration. Polycaprolactone–salt composites are 3D-printed an...

Descripción completa

Detalles Bibliográficos
Autores principales: Shabab, Tara, Bas, Onur, Dargaville, Bronwin L., Ravichandran, Akhilandeshwari, Tran, Phong A., Hutmacher, Dietmar W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220766/
https://www.ncbi.nlm.nih.gov/pubmed/37242582
http://dx.doi.org/10.3390/pharmaceutics15051340
_version_ 1785049295993438208
author Shabab, Tara
Bas, Onur
Dargaville, Bronwin L.
Ravichandran, Akhilandeshwari
Tran, Phong A.
Hutmacher, Dietmar W.
author_facet Shabab, Tara
Bas, Onur
Dargaville, Bronwin L.
Ravichandran, Akhilandeshwari
Tran, Phong A.
Hutmacher, Dietmar W.
author_sort Shabab, Tara
collection PubMed
description This study leverages the advantages of two fabrication techniques, namely, melt-extrusion-based 3D printing and porogen leaching, to develop multiphasic scaffolds with controllable properties essential for scaffold-guided dental tissue regeneration. Polycaprolactone–salt composites are 3D-printed and salt microparticles within the scaffold struts are leached out, revealing a network of microporosity. Extensive characterization confirms that multiscale scaffolds are highly tuneable in terms of their mechanical properties, degradation kinetics, and surface morphology. It can be seen that the surface roughness of the polycaprolactone scaffolds (9.41 ± 3.01 µm) increases with porogen leaching and the use of larger porogens lead to higher roughness values, reaching 28.75 ± 7.48 µm. Multiscale scaffolds exhibit improved attachment and proliferation of 3T3 fibroblast cells as well as extracellular matrix production, compared with their single-scale counterparts (an approximate 1.5- to 2-fold increase in cellular viability and metabolic activity), suggesting that these structures could potentially lead to improved tissue regeneration due to their favourable and reproducible surface morphology. Finally, various scaffolds designed as a drug delivery device were explored by loading them with the antibiotic drug cefazolin. These studies show that by using a multiphasic scaffold design, a sustained drug release profile can be achieved. The combined results strongly support the further development of these scaffolds for dental tissue regeneration applications.
format Online
Article
Text
id pubmed-10220766
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102207662023-05-28 Microporous/Macroporous Polycaprolactone Scaffolds for Dental Applications Shabab, Tara Bas, Onur Dargaville, Bronwin L. Ravichandran, Akhilandeshwari Tran, Phong A. Hutmacher, Dietmar W. Pharmaceutics Article This study leverages the advantages of two fabrication techniques, namely, melt-extrusion-based 3D printing and porogen leaching, to develop multiphasic scaffolds with controllable properties essential for scaffold-guided dental tissue regeneration. Polycaprolactone–salt composites are 3D-printed and salt microparticles within the scaffold struts are leached out, revealing a network of microporosity. Extensive characterization confirms that multiscale scaffolds are highly tuneable in terms of their mechanical properties, degradation kinetics, and surface morphology. It can be seen that the surface roughness of the polycaprolactone scaffolds (9.41 ± 3.01 µm) increases with porogen leaching and the use of larger porogens lead to higher roughness values, reaching 28.75 ± 7.48 µm. Multiscale scaffolds exhibit improved attachment and proliferation of 3T3 fibroblast cells as well as extracellular matrix production, compared with their single-scale counterparts (an approximate 1.5- to 2-fold increase in cellular viability and metabolic activity), suggesting that these structures could potentially lead to improved tissue regeneration due to their favourable and reproducible surface morphology. Finally, various scaffolds designed as a drug delivery device were explored by loading them with the antibiotic drug cefazolin. These studies show that by using a multiphasic scaffold design, a sustained drug release profile can be achieved. The combined results strongly support the further development of these scaffolds for dental tissue regeneration applications. MDPI 2023-04-26 /pmc/articles/PMC10220766/ /pubmed/37242582 http://dx.doi.org/10.3390/pharmaceutics15051340 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Shabab, Tara
Bas, Onur
Dargaville, Bronwin L.
Ravichandran, Akhilandeshwari
Tran, Phong A.
Hutmacher, Dietmar W.
Microporous/Macroporous Polycaprolactone Scaffolds for Dental Applications
title Microporous/Macroporous Polycaprolactone Scaffolds for Dental Applications
title_full Microporous/Macroporous Polycaprolactone Scaffolds for Dental Applications
title_fullStr Microporous/Macroporous Polycaprolactone Scaffolds for Dental Applications
title_full_unstemmed Microporous/Macroporous Polycaprolactone Scaffolds for Dental Applications
title_short Microporous/Macroporous Polycaprolactone Scaffolds for Dental Applications
title_sort microporous/macroporous polycaprolactone scaffolds for dental applications
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220766/
https://www.ncbi.nlm.nih.gov/pubmed/37242582
http://dx.doi.org/10.3390/pharmaceutics15051340
work_keys_str_mv AT shababtara microporousmacroporouspolycaprolactonescaffoldsfordentalapplications
AT basonur microporousmacroporouspolycaprolactonescaffoldsfordentalapplications
AT dargavillebronwinl microporousmacroporouspolycaprolactonescaffoldsfordentalapplications
AT ravichandranakhilandeshwari microporousmacroporouspolycaprolactonescaffoldsfordentalapplications
AT tranphonga microporousmacroporouspolycaprolactonescaffoldsfordentalapplications
AT hutmacherdietmarw microporousmacroporouspolycaprolactonescaffoldsfordentalapplications